RxDoctor Payments Data

Jodi Harvey, MD

Internal Medicine · Loveland, OHNPI 1396708483

Payments from drug & device makers

$1,030in general payments, 2019–2025

Across 82 payments — averaging $12.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$217
  • AstraZeneca$174
  • AbbVie$106
  • Teva Pharmaceuticals USA, Inc.$86
  • Takeda Pharmaceuticals U.S.A., Inc.$73
  • Amarin Pharma, Inc.$68
  • plus $305 from 12 others

What the payments were for

  • Food & beverage$1,01799%
  • Education$131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,030 in reported general payments places this provider in the 70th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$70,144
Medicare patients
222
Services billed
791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide28$54,962
OzempicSemaglutide26$31,109
JanuviaSitagliptin Phosphate27$30,229
EliquisApixaban32$20,041
JardianceEmpagliflozin17$14,212
XareltoRivaroxaban15$13,462
FarxigaDapagliflozin Propanediol17$10,460
Tresiba Flextouch U-200Insulin Degludec17$9,706
LinzessLinaclotide11$5,821
Atorvastatin Calcium532$3,071
Tiotropium Bromide12$2,824
Qvar RedihalerBeclomethasone Dipropionate15$2,768
Levothyroxine Sodium255$2,368
SynthroidLevothyroxine Sodium45$2,192
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,015

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$34$54,96228 claims
Novo NordiskOzempic$217$31,10926 claims
MerckJanuvia$36$30,22927 claims
PfizerEliquis$22$20,04132 claims
Boehringer IngelheimJardiance$28$14,21217 claims
AstraZenecaFarxiga$174$10,46017 claims
AbbVieLinzess, Synthroid$106$8,01356 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$86$2,76815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Loveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →